Tracking Cathie Wood: Took a large position in SpaceX with over 3.29 million shares, and trimmed holdings across multiple dimensions to adjust portfolio structure

The three major U.S. stock indices closed moderately higher last Friday, with the S&P 500 rising 0.50% to close at 7,431.46, the Nasdaq advancing 0.31% to 25,888.84, and the Dow Jones posting the largest gain of 0.70% to close at 51,202.26, reflecting a steady upward market trend.

Cathie Wood's trading activity last Friday exhibited clear signs of strategic portfolio restructuring: she significantly increased her stakes in space exploration stocks while precisely trimming several existing positions, possibly reflecting active portfolio optimization and risk management considerations.

Buying Focus: Concentrated Positioning in the Space Economy

ARK significantly increased its stake in $SpaceX (SPCX.US)$ by 3.29 million shares, demonstrating strong confidence in the space economy sector.

This substantial increase in SpaceX reflects Cathie Wood’s long-term bullish outlook on the 'new space economy,' a disruptive innovation theme. As the leader in commercial aerospace, SpaceX continues to widen its technological moat through reusable rocket systems, satellite internet deployment, and future Mars colonization plans. With surging global demand for satellite internet and the gradual maturation of the space tourism market, ARK likely views SpaceX as standing at a pivotal inflection point for industry takeoff, with significant potential for valuation re-rating.

Selling Focus: Diversified Trims to Optimize Allocation

ARK systematically reduced stakes across multiple holdings spanning healthcare technology, semiconductors, and streaming media sectors. Key positions trimmed include:$Strata Critical Medical (SRTA.US)$ 475,000 shares,$Roku Inc (ROKU.US)$ 99,000 shares,$Advanced Micro Devices (AMD.US)$ 81,000 shares,$Baidu (BIDU.US)$ 67,000 shares, etc.

In-depth analysis: This multi-dimensional reduction in holdings may stem from several considerations. First, the trimming of positions in tech giants such as $Advanced Micro Devices (AMD.US)$ and $Baidu (BIDU.US)$ may reflect ARK’s reassessment of the competitive landscape for AI chips and the regulatory environment for Chinese ADRs. Second, the reduction in healthcare technology stocks like $Strata Critical Medical (SRTA.US)$、$Veracyte (VCYT.US)$ could be driven by caution over overheated sector valuations. Finally, partial reductions in new energy and aerospace stocks such as $Tesla (TSLA.US)$、$Rocket Lab (RKLB.US)$ may aim to lower concentration risk in individual sectors and achieve a more balanced portfolio allocation.

Futubull’s [Opportunities Page] now features celebrity portfolio tracking! Choose from multiple celebrity holdings, follow top investors’ moves with one click, precisely target quality stocks, and invest with greater confidence!

242K Views